NeuPath Health Inc.

Equities

NPTH

CA64133P1009

Healthcare Facilities & Services

Market Closed - Toronto S.E. 03:57:29 2024-04-24 pm EDT 5-day change 1st Jan Change
0.17 CAD +3.03% Intraday chart for NeuPath Health Inc. +6.25% -8.11%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
NeuPath Health Narrows Q4 Loss, Revenue Rises MT
NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
NeuPath Health Inc. acquired Assets of The London Spine Centre from The London Spine Centre. CI
NeuPath Health Reports Q3 2023 Revenue of $16.1 Million, up 6% MT
NeuPath Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
NeuPath Health Inc. Announces Successful Closing of Updated Credit Facility CI
NeuPath Health Closes Sale of Corporate-Owned Medical Facility MT
An unknown buyer completed the acquisition of London medical facility, Ontario from NeuPath Health Inc.. CI
NeuPath Health Swings to Profit in Q2, Revenue Grows MT
NeuPath Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
NeuPath Health Inc. Brief: Record Q2 Total Revenue of $17.1 million MT
NeuPath Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NeuPath Health Closes Brokered Private Placement MT
NeuPath Health Inc. announced that it has received CAD 1.453 million in funding CI
NeuPath Health Inc. announced that it expects to receive CAD 1.4 million in funding CI
NeuPath Health Inc. Brief: Edging Lower Although Says Delivered Record Quarterly Revenues and Opened New Fluoroscopy Suite to Patients MT
NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
NeuPath Health Inc. Auditor Raises 'Going Concern' Doubt CI
NeuPath Health Agrees to Sell Corporate-owned Medical Facility MT
An unknown buyer agreed to acquire London medical facility, Ontario from NeuPath Health Inc.. CI
NeuPath Health Q3 Loss $1.14 Million Vs Loss $0.66 Million Year Ago; Revenue Flat at $15.2 Million MT
NeuPath Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
NeuPath Health Inc Announces Board Changes CI
NeuPath Health Executive Chair Dianne Carmichael Steps Down, Names Interim CEO; Suspends Software Development MT
NeuPath Health Inc. Announces Resignation of Dianne Carmichael as Director and Executive Chair CI
Chart NeuPath Health Inc.
More charts
NeuPath Health Inc. operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging treatments and delivering patient-centered multidisciplinary care. The Company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. It provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. The Company's health care providers cover a range of specialties, which include physiatrists, neurologists, anesthesiologists, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, and nurses.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.17 CAD
Average target price
0.5 CAD
Spread / Average Target
+194.12%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NPTH Stock
  4. News NeuPath Health Inc.
  5. NeuPath Health Narrows Q4 Loss, Revenue Rises